THE INNOVATIVE MEDICINES INITIATIVE
The Innovative Medicines Initiative (IMI) is Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients.
IMI supports collaborative research projects and builds networks of industrial and academic experts in order to boost pharmaceutical innovation in Europe.
IMI is a joint undertaking between the European Union and the pharmaceutical industry association EFPIA.
IMI 10TH CALL LAUNCHED
IMI has launched its 10th Call for proposals with a topic on Immunological assay standardisation & development for use in assessments of correlates of protection for influenza vaccines.
Deadline for applications: 28 January 2014
- 09/12/2013 : RT @Open_PHACTS: The Open PHACTS API received over 8 million hits since its launch in January 2013. Signup for your free API key at http://…
- 09/12/2013 : RT @DeptHealthPress: Tune in here on 11 December to watch live streaming of the #G8Dementia http://t.co/t2hGsXH9EL
- 09/12/2013 : Looking forward #G8dementia on Weds, hope it results in greater collaboration on dementia research - this is urgently needed!